Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5843 record(s)

Req # A-2022-000257

The number of rapid tests distributed to government employees by department for each month and for each product type since September 2020. The number of rapid tests distributed to the private sector by organization during the same timeframe.

Organization: Health Canada

45 page(s)
September 2022

Req # A-2022-000371

The Health Canada approval letter for Vertex Pharmaceutical's trial to be carried out in Canada: A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes (ClinicalTrials.gov Identifier: NCT04786262).

Organization: Health Canada

4 page(s)
September 2022

Req # A-2022-000391

Cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient buprenorphine. Screening…

Organization: Health Canada

4 page(s)
September 2022

Req # A-2022-000392

Cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient desmopressin. Screening…

Organization: Health Canada

4 page(s)
September 2022

Req # A-2022-000394

Cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient thiotepa. Screening…

Organization: Health Canada

5 page(s)
September 2022

Req # A-2022-000421

All receipts for the expense referred to in Sessional Paper 8555-441-494, tabled in the House of Commons on June 8, 2022, with the following vendor, amount, date of expenditure, and file number: Gilles Blais Distribution, $77.32, March 17th, 2022,…

Organization: Health Canada

0 page(s)
September 2022

Req # A-2022-000428

All receipts for the expense referred to in Sessional Paper 8555-441-494, tabled in the House of Commons on June 8, 2022, with the following vendor, amount, date of expenditure, and file number: Food Fare QPS WI, $142.40 March 25th, 2022, 241926

Organization: Health Canada

0 page(s)
September 2022

Req # A-2022-000464

Cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredients lidocaine-prilocaine.

Organization: Health Canada

3 page(s)
September 2022

Req # A-2022-000630

The driving factors for management in the Health Product and Food Branch (HPFB) and the governing hierarchy, the criteria for achieving the performance pay for all HPFB executives, by position. Records for the following fiscal years. (2019-2020,…

Organization: Health Canada

70 page(s)
September 2022

Req # A-2022-000660

Le détail en regard de toutes procédures, demandes ou recours actuellement actifs ou en cours ou pendant ou de tout solde qui vous est dû par cette Société. Société : Dizal inc. (NEQ : 1171554497) 108-4000, rue Jean-Marchand, Québec (Québec) G2C 1Y6.

Organization: Health Canada

0 page(s)
September 2022
Date modified: